What is the Special Lecture?
SB also provides a platform for subject matter experts in the medtech innovation process e.g. regulatory, design thinking; as well as in various domain clinical specialties and geographies to share their experiences and insights with the local community.
Upcoming Special Lectures
Past Special Lectures
|2019||Healthtech investing: Battle of the heavyweights||
Dr. Josh Makower, General Partner, NEA
Moderator: Dr. Joseph Mocanu, Managing Partner, Verge HealthTech Fund
For more information, click here.
|2015||Innovations in Cardiac Surgery||
Mr. Manny Villafana, Founder, St. Jude Medical Inc.
|2015||Leading with Creative Confidence||
Mr. Tom Kelley, Partner, IDEO
|2014||International Trends in Medical Technology Innovation & Regulation||
Mr. Michael Gropp, Former VP, Global Regulatory Strategy, Medtronic
|2013||The futre of medical and life sciences technology: Changing the Paradigm from treating disease to disease Management||
Mr. William Hawkins, Ex-CEO, Medtronic
|2012||MedTech Ventures in China||
Dr. Chris Shen, MD, Executive Director (US), Singapore-Stanford Biodesign, Principal, Essex Woodlands.
|2012||Presentations on Personalised Medicine 24 Feb 2012, Matrix, Biopolis||
The Health Sciences Authority (HSA) together with the Singapore-Stanford Biodesign (SSB) presentated two guest speakers, Karen Long and Carolyn Albertson, from Abbott. Key issues on safety, effectiveness and cost were addressed, in this presentation, for the effective translation of scientific innovation into clinical practice. Molecular technology can play a role for the greater understanding on the molecular basis of disease which holds much promise for the personalisation of diagnostic approaches, optimal for each individual.
|2011||Healthcare innovators Forum Keynote||
Mr Peh Ruey Feng, SSB fellowship head, was a keynote speaker at the "Healthcare Innovators Forum 2011" held by the Ministry of Health and Singapore Economic Development Board on 28th October 2011. His talk entitled "Needs Driven Inventions, Commercialisation Centric Innovations", Mr Peh Ruey Feng share about the Biodesign Innovation Process: a systematic approach to needs identification, invention and implementation of a new medical technology; and innovation principles that can help improve the odds of success.
Speakers at the Forum: